CDK6 and lung cancer: Activated cyclin-dependent kinase-6 and cyclin-dependent kinase-2 during the G1–S cell-cycle transition are key regulators in the modifications of retinoblastoma pathway (27), disruption of which shows strong cell-proliferative activity and has been shown to play important roles in the pathogenesis of lung cancer (28).